SensVita, Inc.

SensVita is advancing at-home healthcare delivery with next-generation touchless sensors for continuous and passive cardiopulmonary monitoring. Its patented technology captures a wide range of vital cardiac and respiratory endpoints without any skin contact, enabling seamless integration into over-clothes wearables or furniture-embedded sensing pads. This approach addresses one of the most critical challenges in remote monitoring—low patient compliance.

Serida Inc.

Serida is an agrivoltaic design studio founded in a Cornell University engineering lab. Its proprietary software enables solar developers to optimize site deployment and crop selection to maximize both renewable energy production and agricultural yield. Serida provides data-driven tools that streamline project evaluation and reduce risk in agrivoltaic deployment.

MAV Unlimited

MAV Unlimited has developed the largest and fastest volumetric additive manufacturing machine (3D printer) in the world, and we believe it has the potential to transform how and where products are made across a range of industries, delivering meaningful economic and environmental benefit to the globe.

Gallox Semiconductors, Inc.

Gallox produces ultrawide bandgap gallium oxide (Ga203) semiconductor devices that eliminate that inefficiency, enable more powerful electronics circuitry, and reduce a system’s size, weight and engineering complexity.

EchoICs, Inc.

EchoICs is developing a reconfigurable radio platform with extended battery life, enhanced dynamic range, reduced size and system cost that allows improvement in output power, system efficiency, and receiver linearity.

Vescor Therapeutics Inc.

Vescor Therapeutics Inc., is an immuno-oncology company that is developing new therapies that modulate endoplasmic reticulum (ER) stress response pathways in the tumor microenvironment. Chronic activation of this stress response is linked to poor outcomes in multiple cancers, such as ovarian cancer, triple-negative breast cancer, pancreatic adenocarcinoma and glioblastoma. The company was founded based on intellectual property generated from Weill Cornell Medicine and is developing small molecule therapeutics that inhibit the enzyme IRE1α.

Anova Biomedical

Anova Biomedical is developing synthetic bioresorbable grafts to enable long-term, incident-free hemodialysis. The technology originated in Professor Yadong Wang’s lab and is spun out thanks to the Ignite Fellow for New Venture program, a startup accelerator from Cornell.

ExoPower, Inc

ExoPower is revolutionizing charging for mobile robots by solving the battery charging issue through ​an in-motion capacitive wireless solution.

Graphenode, Inc.

Leveraging the latest in nanotechnology, Graphenode’s patent-pending SiGraph™ anode additive encases silicon in a graphene nanoweb to harness silicon’s superior energy density.